Breast cancer is the most common cancer among women in Malaysia, representing approximately 32% of all cancers diagnosed in Malaysian women, according to the Malaysian National Cancer Registry. This makes Malaysia one of the countries in Southeast Asia with the highest breast cancer burden relative to its population — alongside Indonesia, Thailand and the Philippines.
What makes Malaysia's situation particularly concerning is the combination of rising incidence, low screening rates and a pattern of late-stage presentation. Survival outcomes in Malaysia, while improving, remain significantly below those in the UK and other high-income countries — largely because too many women are not diagnosed until their cancer has already reached stage III or IV.
Malaysia's breast cancer statistics
- Breast cancer is the leading cancer in Malaysian women, accounting for roughly 32% of all female cancer diagnoses.
- Approximately 8,000–9,000 new breast cancer cases are diagnosed in Malaysia each year (GLOBOCAN 2022).
- The age-standardised incidence rate is approximately 38 per 100,000 women — below the UK rate of approximately 99 per 100,000, but rising.
- Around 50–60% of breast cancers in Malaysia are diagnosed at stage III or IV, compared to the UK where the majority are diagnosed at stage I or II.
- Five-year survival rates in Malaysia are estimated at approximately 60–70%, compared to approximately 87% in the UK.
- Breast cancer in Malaysia is diagnosed at a younger average age than in the UK — many diagnoses occur in women aged 40–50.
The ethnic dimension — Chinese, Malay and Indian women
Malaysia is a multi-ethnic nation, and breast cancer statistics vary across its main ethnic groups. Chinese Malaysian women have the highest incidence of breast cancer of the three main ethnic groups, broadly consistent with patterns seen in ethnic Chinese populations across Southeast Asia. Malay women, who predominantly follow Islamic cultural norms around modesty and may have greater hesitancy about breast examination, have historically had lower reported incidence but also lower screening rates.
Across all ethnic groups, diagnosis at an advanced stage is a significant problem. Awareness campaigns have typically been concentrated in urban areas, leaving rural and indigenous communities with limited access to information and services.
Why is late diagnosis so common in Malaysia?
- No universal organised screening programme: Malaysia does not have an organised national breast cancer screening programme comparable to the UK's NHS Breast Screening Programme. The national health screening programme includes a mammogram recommendation for women over 40, but uptake is low and delivery is inconsistent.
- Low awareness: Studies conducted in Malaysia have found significant gaps in breast cancer knowledge among women in rural areas and among older women. Many women are not aware of the standard warning signs or the importance of acting on them promptly.
- Cultural barriers: In some communities — particularly among more conservative Muslim women — modesty concerns and the stigma around discussing the breast make it difficult to seek timely medical care or participate in mammography screening.
- Geographic access: Malaysia's rural areas, particularly in Sabah, Sarawak and the interior of the peninsula, have limited access to mammography machines and specialist oncology services. Women in these areas may face long journeys to access basic diagnostic care.
- Cost: While Malaysia has a public healthcare system, waiting times can be long, and some women opt for private care which carries significant out-of-pocket costs. The cost of mammography, biopsy, chemotherapy and radiotherapy in the private sector is beyond the reach of many Malaysian families.
- Fatalism and traditional medicine: Some women delay or avoid seeking conventional medical treatment due to fatalism ('what happens is God's will') or a preference for traditional herbal remedies. By the time cancer is severe enough that these approaches are abandoned, it has often progressed significantly.
What is being done to improve outcomes in Malaysia
The Malaysian Ministry of Health has made breast cancer a public health priority. The National Cancer Control Programme includes breast cancer awareness campaigns, training of primary care physicians in clinical breast examination, and subsidised mammography at government health clinics. The Malaysian Society of Oncology and breast cancer patient advocacy groups have run awareness campaigns in multiple languages — Malay, Mandarin, Tamil and English.
Mobile mammography units have been deployed in some rural areas, funded by a combination of government and non-governmental sources. However, the scale of these initiatives remains insufficient relative to the population's need.
The role of international charitable support
International organisations working on breast cancer equity play an important role in supplementing national efforts. Mobile screening clinics, training of community health workers, and funding for clinical breast examinations and ultrasounds in communities with limited access to formal healthcare can make a meaningful difference in early detection rates.
The evidence is clear: early detection dramatically improves survival. A woman whose breast cancer is found at stage I has a survival rate close to 98–100%. A woman whose cancer is found at stage IV has a survival rate of around 26%. Closing this gap requires investment at every level — national policy, local health infrastructure, community awareness and international support.
